Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-17 Sale | 2024-01-19 5:19 pm | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 9,786 | $17.23 | $168,613 | 216,860 (Indirect Direct) | View |
| 2023-08-03 Sale | 2023-08-07 8:50 pm | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 34,919 | $20.01 | $698,581 | 298,171 (Indirect Direct) | View |
| 2023-07-17 Sale | 2023-07-19 8:26 pm | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 17,937 | $18.01 | $323,029 | 250,974 (Indirect Direct) | View |
| 2023-03-30 Sale | 2023-04-03 6:51 pm | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 9,036 | $26.52 | $239,643 | 233,755 (Indirect Direct) | View |
| 2022-12-20 Sale | 2022-12-21 9:32 pm | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 8,748 | $19.1 | $167,108 | 169,982 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-23 Option Award | 2024-01-24 4:57 pm | N/A 2034-01-23 | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 94,500 | $0 | 311,360 (Direct) | View |
| 2023-08-03 Exercise | 2023-08-07 8:50 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 10,591 | $2.08 | 298,171 (Direct) | View |
| 2023-08-03 Exercise | 2023-08-07 8:50 pm | N/A 2028-03-31 | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 10,591 | $0 | 298,171 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-18 7:19 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 35,156 | $0 | 268,911 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:59 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 17,578 | $0 | 242,791 (Direct) | View |
| 2023-01-25 Option Award | 2023-01-27 7:15 pm | N/A 2033-01-24 | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 130,200 | $0 | 300,182 (Direct) | View |
| 2022-12-19 Option Award | 2022-12-21 9:32 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 17,578 | $0 | 169,982 (Direct) | View |
| 2022-01-26 Option Award | 2022-02-02 8:14 pm | N/A 2032-01-25 | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 112,500 | $0 | 112,500 (Direct) | View |
| 2021-05-26 Exercise | 2021-05-28 7:58 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 4,500 | $2.08 | 170,016 (Direct) | View |
| 2021-05-26 Exercise | 2021-05-28 7:58 pm | N/A 2029-01-23 | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 4,500 | $0 | 170,016 (Direct) | View |
| 2021-01-23 Option Award | 2021-01-26 8:00 pm | N/A 2031-01-22 | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 62,250 | $0 | 62,250 (Direct) | View |
| 2020-12-30 Exercise | 2021-01-04 8:00 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 3,500 | $2.08 | 170,016 (Direct) | View |
| 2020-12-30 Exercise | 2021-01-04 8:00 pm | N/A 2029-01-23 | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 3,500 | $0 | 170,016 (Direct) | View |
| 2020-02-28 Option Award | 2020-06-09 9:24 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 27,322 | $13.08 | 246,711 (Indirect) | View |
| 2020-03-31 Option Award | 2020-06-09 9:24 pm | N/A 2030-03-30 | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 70,352 | $0 | 246,711 (Direct) | View |
| 2020-06-05 Conversion | 2020-06-09 9:24 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 72,541 | $0 | 246,711 (Direct) | View |
Ownership | 2020-06-02 9:03 pm | N/A N/A | PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer | 0 | $0 | 282,326 (Direct) | View |